---
title: To Determine the Therapeutic Effect of the Music Glove and Conventional Hand Exercises to Subacute Stroke Patients
nct_id: NCT02410629
overall_status: COMPLETED
phase: NA
sponsor: David Reinkensmeyer
study_type: INTERVENTIONAL
primary_condition: Cerebrovascular Accident
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02410629.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02410629"
ct_last_update_post_date: 2022-10-13
last_seen_at: "2026-05-12T06:24:22.785Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# To Determine the Therapeutic Effect of the Music Glove and Conventional Hand Exercises to Subacute Stroke Patients

**Official Title:** Influence of Timing on Motor Learning

**NCT ID:** [NCT02410629](https://clinicaltrials.gov/study/NCT02410629)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 17
- **Lead Sponsor:** David Reinkensmeyer
- **Conditions:** Cerebrovascular Accident
- **Start Date:** 2015-03
- **Completion Date:** 2016-07
- **CT.gov Last Update:** 2022-10-13

## Brief Summary

The investigators are trying to determine the therapeutic effect of the music glove and conventional hand exercise program to the subacute stroke patients. All participants will be randomized into two groups: AB and BA. They will all exercise at least 3 times a week for 3 weeks with a minimal 3 hours exercise time per week. Participants will receive the other intervention at 3-month post stroke date. Clinical evaluations will be performed at baseline, post therapy after first intervention, 3-week post intervention follow up, 3-month post stroke, post therapy after second intervention, 3-week post second intervention follow up, and 6-month post stroke follow up visits.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 80 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* History of a single stroke at least 1 week prior to enrollment
* Upper Extremity weakness measured on a standard clinical scale
* No active major psychiatric problems, or neurological/orthopedic problems affecting the stroke affected upper extremity
* No active major neurological disease other than the stroke
* Absence of pain in the affected upper extremity

Exclusion Criteria:

* Severe tone at the affected upper extremity as measured on a standard clinical scale
* Severe aphasia as measured on a standard clinical scale
* Severe reduced level of consciousness
* Severe sensory/proprioception deficit at the affected upper extremity as measured on a standard clinical scale
* Currently pregnant
* Difficulty in understanding or complying with instructions given by the experimenter
* Inability to perform the experimental task that will be studied
* Increased pain with movement of the affected upper extremity
```

## Arms

- **Music Glove** (EXPERIMENTAL) — Music Glove is a glove with sensors attached to the tips of all 5 fingers. The glove is connected to a software musical program like guitar hero. Participants will follow the rhythm or musical notes of the songs and move their fingers accordingly. Participants are reinforced with biofeedback that includes visual and auditory cues when the correct sequences are achieved.
- **Conventional Hand Exercise Program** (ACTIVE_COMPARATOR) — Conventional Hand Exercise Program includes range of motion exercises, strengthening exercises, coordinating exercises of the hand and fingers. This exercise program is designed by an occupational therapist and is a general exercise program that a stroke patient will receive when he/she is being discharged from the hospital.

## Interventions

- **Music Glove** (DEVICE) — Participants will exercise at home using the music glove for 3 times a week for 3 weeks with a minimal of 3 hours per week.
- **Conventional Hand Exercise Program** (OTHER) — Participants will exercise at home using the hand exercise program designed by an occupational therapist for 3 times a week for 3 weeks with a minimal of 3 hours per week.

## Primary Outcomes

- **Box and Block Test** _(time frame: From baseline to end of therapy (3 weeks))_ — We compared the change of Box and Block Test scores from baseline evaluation to the end of 3-week of therapy (Intervention 1), and from 12-week post-stroke to end of 3-week therapy (Intervention 2). Participants are instructed to move as many blocks as possible, one at a time, from one compartment in a box to a second compartment over a divider for a period of 60 seconds; each block that is moved is counted, and multiple blocks moved at the same time are counted as a single block. The higher scores indicates a better outcome.

## Secondary Outcomes

- **Fugl-Meyer Motor Assessment of the Upper Extremity** _(time frame: From baseline to end of therapy (3 weeks))_
- **Action Research Arm Test** _(time frame: From baseline to end of therapy (3 weeks))_
- **9-Hole Peg Test** _(time frame: From baseline to end of therapy (3 week))_

## Locations (1)

- University of California, Irvine, Irvine, California, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.university of california, irvine|irvine|california|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02410629.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02410629*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*